Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Morbidity and Mortality Conference: How Do We Learn From Special Cases?

The Annals of otology, rhinology, and laryngology·2024
Same author

Re-evaluation of the methodology for estimating the US specialty physician workforce.

Health affairs scholar·2024
Same author

Relationship between otolaryngology interest groups and residency match results.

American journal of otolaryngology·2024
Same author

Assessing ChatGPT's Responses to Otolaryngology Patient Questions.

The Annals of otology, rhinology, and laryngology·2024
Same author

Demographic disparities in children with retropharyngeal and parapharyngeal abscesses.

American journal of otolaryngology·2023
Same author

Advances in the Use of Hypoglossal Nerve Stimulator in Adolescents With Down Syndrome and Persistent Obstructive Sleep Apnea-A Systematic Review.

The Annals of otology, rhinology, and laryngology·2023

Related Experiment Video

Updated: May 24, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

P53 and the proteasome regulate androgen receptor activity.

Natalya V Guseva1, Oskar W Rokhlin, Rebecca A Glover

  • 1Department of Pathology, University of Iowa, Iowa City, Iowa, USA. natalya-guseva@uiowa.edu

Cancer Biology & Therapy
|March 13, 2012
PubMed
Summary

The tumor suppressor p53 influences androgen receptor (AR) activity. Proteasome inhibitors show reduced efficacy in inhibiting AR when p53 is present, suggesting p53 status impacts treatment effectiveness in prostate cancer.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Experiment Videos

Last Updated: May 24, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Mutual regulation between p53 and the androgen receptor (AR) is established.
  • The precise role of p53 in modulating AR expression and activity requires further elucidation, particularly in the context of prostate cancer.

Purpose of the Study:

  • To investigate how p53 influences androgen receptor (AR) expression and activity.
  • To determine the role of p53 in proteasome-dependent inhibition of AR activity.

Main Methods:

  • Utilized ARE-Luciferase reporter assays in LNCaP and PC3 cell lines with varying p53 and AR statuses.
  • Quantitatively assessed AR activity following treatment with proteasome inhibitors (lactacystin).
  • Measured AR-DNA binding affinity in response to proteasome inhibition.

Main Results:

  • p53 expression decreased DHT-dependent activity of wild-type AR.
  • Proteasome inhibitor lactacystin significantly inhibited AR activity and AR-DNA binding in LNCaP cells.
  • LNCaP-sip53 transfectants showed no inhibition of AR activity or AR-DNA binding by lactacystin.
  • The inhibitory effects of proteasome inhibitors on AR activity are dependent on p53 status.

Conclusions:

  • p53 status is a critical determinant of the efficacy of proteasome inhibitors in modulating AR activity in prostate cancer.
  • Further investigation into the role of p53 in tumors treated with proteasome inhibitors is warranted.